Biophytis News

BPTSDelisted Stock  USD 7.03  0.00  0.00%   
Slightly above 56% of Biophytis' investor base is looking to short. The analysis of current outlook of investing in Biophytis suggests that many traders are alarmed regarding Biophytis' prospects. Biophytis' investing sentiment can be driven by a variety of factors including economic data, Biophytis' earnings reports, geopolitical events, and overall market trends.
  
over three months ago at news.google.com         
Biophytis SA Expands Asian Market Presence - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
H.C. Wainwright optimistic on Biophytis stock as Phase 2 trial approved - Investing.com India
Google News at Macroaxis
over three months ago at news.google.com         
Biophytis Obtains IND Approval from the FDA to Start its Phase 2 OBA Study in Obesity - StockTitan
Google News at Macroaxis
over three months ago at news.google.com         
Biophytis Announces Promising COVID-19 Study Results - TipRanks.com - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Biophytis grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at up to 108 Mil...
Google News at Macroaxis
over three months ago at news.google.com         
Biophytis Extends Its Contract With Atlas to Secure Financing for Its Business Activities - StockTit...
Google News at Macroaxis
over six months ago at news.google.com         
Biophytis Advances DMD Treatment with BIO101 Scale-Up - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
Biophytis SA Announces Upcoming General Meeting - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
FY2024 Earnings Forecast for Biophytis S.A. Issued By HC Wainwright - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Biophytis unveils design for obesity study - Marketscreener.com
Google News at Macroaxis
over six months ago at seekingalpha.com         
Biophytis announces transfer of ADSs to OTC Market following Nasdaq delisting
seekingalpha News
over six months ago at accesswire.com         
Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity
news
over six months ago at news.google.com         
Biotech Catches Major Premarket Bid Following Financial Results - MSN
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Why Is Penny Stock Biophytis Trading Higher On Tuesday?
Yahoo News
over six months ago at investorplace.com         
Why Is Vincerx Pharma Stock Down 64 percent Today?
sbwire news
Far too much social signal, news, headlines, and media speculation about Biophytis that are available to investors today. That information is available publicly through Biophytis media outlets and privately through word of mouth or via Biophytis internal channels. However, regardless of the origin, that massive amount of Biophytis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biophytis news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biophytis relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biophytis' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biophytis alpha.

Biophytis Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Biophytis launches OBA phase 2 clinical study in obesity with BIO101
04/08/2024
2
Why Is Biophytis Stock Up 43 percent Today
04/09/2024
3
Biotech Catches Major Premarket Bid Following Financial Results - MSN
04/15/2024
4
Biophytis unveils design for obesity study - Marketscreener.com
05/14/2024
5
Biophytis Advances DMD Treatment with BIO101 Scale-Up - TipRanks.com - TipRanks
06/14/2024
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Biophytis Stock

If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stocks Directory
Find actively traded stocks across global markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Valuation
Check real value of public entities based on technical and fundamental data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.